Hubbell Incorporated
Hubbell Incorporated (HUBB) Financial Performance & Income Statement Overview
Explore the financials of Hubbell Incorporated (HUBB), including yearly and quarterly data on income, cash flow, and balance sheets.
Hubbell Incorporated (HUBB) Income Statement & Financial Overview
Review Hubbell Incorporated HUBB income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.37B | $1.33B | $1.44B | $1.45B |
| Cost of Revenue | $914.00M | $883.70M | $945.50M | $941.70M |
| Gross Profit | $451.20M | $450.60M | $497.10M | $510.80M |
| Gross Profit Ratio | $0.33 | $0.34 | $0.34 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $212.20M | $192.50M | $193.30M | $205.20M |
| Operating Expenses | $212.20M | $193.90M | $193.30M | $205.20M |
| Total Costs & Expenses | $1.13B | $1.08B | $1.14B | $1.15B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $14.20M | $18.70M | $19.80M |
| Depreciation & Amortization | $46.70M | $53.30M | $49.30M | $49.60M |
| EBITDA | $280.40M | $311.70M | $347.50M | $355.30M |
| EBITDA Ratio | $0.21 | $0.23 | $0.24 | $0.24 |
| Operating Income | $239.00M | $258.10M | $303.80M | $305.60M |
| Operating Income Ratio | $0.18 | $0.19 | $0.21 | $0.21 |
| Other Income/Expenses (Net) | -$19.10M | -$13.90M | -$24.30M | -$21.00M |
| Income Before Tax | $219.90M | $244.20M | $279.50M | $280.20M |
| Income Before Tax Ratio | $0.16 | $0.18 | $0.19 | $0.19 |
| Income Tax Expense | $48.90M | $46.00M | $58.50M | $65.00M |
| Net Income | $169.70M | $197.00M | $219.40M | $213.60M |
| Net Income Ratio | $0.12 | $0.15 | $0.15 | $0.15 |
| EPS | $3.16 | $3.66 | $4.08 | $3.97 |
| Diluted EPS | $3.15 | $3.64 | $4.06 | $3.94 |
| Weighted Avg Shares Outstanding | $54.00M | $54.00M | $53.70M | $53.70M |
| Weighted Avg Shares Outstanding (Diluted) | $54.00M | $54.00M | $54.00M | $54.10M |
The company's financials show resilient growth, with revenue advancing from $1.45B in Q2 2024 to $1.37B in Q1 2025. Gross profit remained healthy with margins at 33% in Q1 2025 compared to 35% in Q2 2024. Operating income hit $239.00M last quarter, sustaining a consistent 18% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $280.40M. Net income dropped to $169.70M, while earnings per share reached $3.16. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan